Jim Cramer: Allergan Can Rise Without Pfizer Deal

The Allergan (AGN) - Get Report tax inversion deal with Pfizer (PFE) - Get Report  may be dead, but that does not mean Allergan's stock is also finished, said TheStreet's Jim Cramer. He said the government went out of its way to put the kibosh on the merger even after Treasury Secretary Jack Lew repeatedly said that it would be nearly impossible to stop such deals from taking place.

At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.